Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant  ☒ 
Filed by a Party other than the Registrant  ☐
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12

Salarius Pharmaceuticals, Inc.

(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
 
No fee required.
   
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.




https://cdn.kscope.io/3c0aa168eec2fd5ca29413c1f921b72d-defa14a1a.jpg



https://cdn.kscope.io/3c0aa168eec2fd5ca29413c1f921b72d-defa14a2a.jpg





https://cdn.kscope.io/3c0aa168eec2fd5ca29413c1f921b72d-defa14a3a.jpg




https://cdn.kscope.io/3c0aa168eec2fd5ca29413c1f921b72d-defa14a4a.jpg